Carregant...
p53 protects against LPS-induced lung endothelial barrier dysfunction
New therapies toward heart and blood vessel disorders may emerge from the development of Hsp90 inhibitors. Several independent studies suggest potent anti-inflammatory activities of those agents in human tissues. The molecular mechanisms responsible for their protective effects in the vasculature re...
Guardat en:
Publicat a: | Am J Physiol Lung Cell Mol Physiol |
---|---|
Autors principals: | , , , , , |
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
American Physiological Society
2015
|
Matèries: | |
Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4398875/ https://ncbi.nlm.nih.gov/pubmed/25713322 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajplung.00334.2014 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|